Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 18Hematologic Neoplasms 10Prostatic Neoplasms 9Colorectal Neoplasms 9Breast Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 8Carcinoma, Non-Small-Cell Lung 7Anatomic Stage I Breast Cancer AJCC v8 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Neoplasms 4Hematopoietic and Lymphoid System Neoplasm 4Head and Neck Carcinoma 4Breast Carcinoma In Situ 4Triple Negative Breast Neoplasms 3Multiple Myeloma 3Melanoma 3Malignant Solid Neoplasm 3Lymphoma 3Leukemia, Myeloid, Acute 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Papillomavirus Infections 2Mouth Neoplasms 2Head and Neck Neoplasms 2

Interventions

Etoposide 7Cisplatin 7fludarabine 4Cyclophosphamide 4fludarabine phosphate 3Paclitaxel 3Carboplatin 3Bleomycin 3Automobiles 3pembrolizumab 2etoposide phosphate 2Vorinostat 2Sirolimus 2Mesna 2Ifosfamide 2Drug Therapy 2130-nm albumin-bound paclitaxel 2tremelimumab 1sodium thiosulfate 1repotrectinib 1pralsetinib 1pegfilgrastim 1lutetium Lu 177 dotatate 1durvalumab 1cabozantinib 1Watchful Waiting 1Teniposide 1Surveys and Questionnaires 1Stem Cell Transplantation 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Practice Guidelines as Topic × 1 year × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡